Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 1-20 of 149

Title Anticipated publication date Referral date Process
Venous thromboembolism - apixaban (acute medical illness) [ID310] TBC Jan 2010 STA
Venous thromboembolism (VTE) - ximelagatran [ID396] TBC Oct 2000 MTA
Venous thromboembolism (recurrent) - idraparinux sodium [ID395] TBC Nov 2005 STA
Venous thromboembolism (prevention) - rivaroxaban [ID463] TBC May 2011 STA
Venous leg ulcers - new treatments [ID394] TBC Jun 2003 MTA
Ulcerative colitis (moderate to severely active) - vedolizumab [ID691] Jun 2015 Dec 2013 STA
Ulcerative colitis (moderate, severe) - infliximab (review TA140), adalimumab (review TA262) & golimumab (2nd line) [ID695] Jan 2015 MTA
Thrombophilia [ID393] TBC Oct 2000 MTA
T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin [ID504] TBC Nov 2011 STA
Systemic lupus erythematosus - prasterone [ID392] TBC Oct 2000 MTA
Systemic lupus erythematosus (autoantibody-positive) - belimumab [ID416] TBC Nov 2010 STA
Soft tissue or bone sarcoma (metastatic) - ridaforolimus (maintenance) [ID415] TBC Sep 2011 STA
Rheumatoid arthritis - tofacitinib [ID526] TBC May 2012 STA
Rheumatoid arthritis - adalimumab, etanercept and infliximab (sequential use) [ID18] TBC Jun 2004 MTA
Rheumatoid arthritis - adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, abatacept and tocilizumab - review [ID537] TBC MTA
Rheumatoid arthritis (after the failure of conventional DMARDs) -rituximab [ID333] TBC Apr 2010 STA
Renal transplantation (children, adolescents) - immunosuppressive regimens (review of TA99) [ID346] TBC MTA
Renal transplantation (adults) - immunosuppressive therapy (including Review of TA 85) [ID456] Sep 2014 MTA
Renal cell carcinoma (second line metastatic) - pazopanib [ID70] Jan 2011 Nov 2008 STA
Renal cell carcinoma (advanced) - axitinib [ID518] Jun 2014 Feb 2012 STA

This page was last updated: 22 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.